Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leg ulceration in venous and arteriovenous insufficiency: assessment and management with compression therapy as part of a holistic wound‑healing strategy.
Nair HK, Mosti G, Atkin L, Aburn R, Ali Hussin N, Govindarajanthran N, Narayanan S, Ritchie G, Samuriwo R, Sandy-Hodgetts K, Smart H, Sussman G, Ehmann S, Lantis J, Moffatt C, Naude L, Probst S, White W. Nair HK, et al. Among authors: ehmann s. J Wound Care. 2024 Oct 1;33(Sup10b):S1-S31. doi: 10.12968/jowc.2024.33.Sup10b.S1. J Wound Care. 2024. PMID: 39401103 Free article. No abstract available.
Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection.
Anthofer M, Windisch M, Haller R, Ehmann S, Wrighton S, Miller M, Schernthanner L, Kufferath I, Schauer S, Jelušić B, Kienesberger S, Zechner EL, Posselt G, Vales-Gomez M, Reyburn HT, Gorkiewicz G. Anthofer M, et al. Among authors: ehmann s. Front Immunol. 2024 Jan 22;15:1282680. doi: 10.3389/fimmu.2024.1282680. eCollection 2024. Front Immunol. 2024. PMID: 38318189 Free PMC article.
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.
Zammarrelli WA 3rd, Ma W, Espino K, Gordhandas S, Yeoshoua E, Ehmann S, Zhou Q, Iasonos A, Abu-Rustum NR, Aghajanian C, Green AK, Rubinstein MM, Makker V. Zammarrelli WA 3rd, et al. Among authors: ehmann s. Gynecol Oncol. 2023 Nov;178:27-35. doi: 10.1016/j.ygyno.2023.09.010. Epub 2023 Sep 23. Gynecol Oncol. 2023. PMID: 37748268 Free PMC article.
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Sia TY, Manning-Geist BL, Ehmann S, Lavery JA, Luardo C, Praiss A, Iasonos A, Sonoda Y, Grisham RN, Liu YL, Broach V, Zivanovic O, Long Roche K, Gardner GJ, Chi DS. Sia TY, et al. Among authors: ehmann s. Gynecol Oncol. 2023 Sep;176:69-75. doi: 10.1016/j.ygyno.2023.07.006. Epub 2023 Jul 14. Gynecol Oncol. 2023. PMID: 37454565 Free PMC article.
40 results